Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena I Boshoff

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Journal of the American Chemical Society|February 1, 2011
Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malariaMarvin J Miller, Andrew J Walz, Helen Zhu, et al.
Mbio|November 1, 2016
Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T LymphocytesDiego L Costa, Sivaranjani Namasivayam, Eduardo P Amaral, et al.
The FEBS Journal|October 26, 2011
Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazolesMeera Gurumurthy, Tathagata Mukherjee, Cynthia S Dowd, et al.
Plos One|October 7, 2015
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular CompoundsMagdalena Makowska-Grzyska, Youngchang Kim, Suresh Kumar Gorla, et al.
ACS Infectious Diseases|September 28, 2016
Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestisGéraldine San Jose, Emily R Jackson, Amanda Haymond, et al.
Journal of Medicinal Chemistry|February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationshipsPilho Kim, Sunhee Kang, Helena I Boshoff, et al.
Journal of Ethnopharmacology|June 10, 2014
Some Nigerian anti-tuberculosis ethnomedicines: a preliminary efficacy assessmentNneka N Ibekwe, John B Nvau, Peters O Oladosu, et al.
Journal of the American Chemical Society|October 8, 2009
Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signalsColin A Lowery, Junguk Park, Christian Gloeckner, et al.
European Journal of Medicinal Chemistry|August 27, 2021
Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitorsLijun Song, Romain Merceron, Fabian Hulpia, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosisYumi Park, Yong-Mo Ahn, Surendranadha Jonnala, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Journal of the American Chemical Society|February 1, 2011
Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malariaMarvin J Miller, Andrew J Walz, Helen Zhu, et al.
Mbio|November 1, 2016
Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T LymphocytesDiego L Costa, Sivaranjani Namasivayam, Eduardo P Amaral, et al.
The FEBS Journal|October 26, 2011
Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazolesMeera Gurumurthy, Tathagata Mukherjee, Cynthia S Dowd, et al.
Plos One|October 7, 2015
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular CompoundsMagdalena Makowska-Grzyska, Youngchang Kim, Suresh Kumar Gorla, et al.
ACS Infectious Diseases|September 28, 2016
Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestisGéraldine San Jose, Emily R Jackson, Amanda Haymond, et al.
Journal of Medicinal Chemistry|February 13, 2009
Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationshipsPilho Kim, Sunhee Kang, Helena I Boshoff, et al.
Journal of Ethnopharmacology|June 10, 2014
Some Nigerian anti-tuberculosis ethnomedicines: a preliminary efficacy assessmentNneka N Ibekwe, John B Nvau, Peters O Oladosu, et al.
Journal of the American Chemical Society|October 8, 2009
Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signalsColin A Lowery, Junguk Park, Christian Gloeckner, et al.
European Journal of Medicinal Chemistry|August 27, 2021
Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitorsLijun Song, Romain Merceron, Fabian Hulpia, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosisYumi Park, Yong-Mo Ahn, Surendranadha Jonnala, et al.
Pageof 10